“If this blog helped you out, don’t keep it to yourself—share the link on your socials!” 👍 “Like what you read? Spread the love and share this blog on your social media.” 👍 “Found this useful? Hit share and let your friends know too!” 👍 “If you enjoyed this post, please share the URL with your friends online.” 👍 “Sharing is caring—drop this link on your social media if it helped you.”

Saturday, August 30, 2025

Avanir Pharmaceuticals


Avanir Pharmaceuticals products


NUEDEXTA (dextromethorphan/quinidine)
Indication: Treatment of pseudobulbar affect (PBA), characterized by involuntary laughing or crying episodes.

ONZETRA Xsail (sumatriptan powder intranasal)
Indication: Acute treatment of migraine; delivered via a breath-powered intranasal, dry powder system.

AVP-786 (deudextromethorphan/quinidine; deuterated)
Indication: Investigational therapy for agitation in Alzheimer’s dementia, among other neurologic or psychiatric disorders. Advanced in Phase III development.



on

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)